Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...
Ben Pauling is relishing the prospect of a Cheltenham Gold Cup that promises to be like the classics of old – and thinks he has not one but two real chances of winning it. Pauling was speaking to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback